Tern plc Investor Webinar Recording in Full (VIDEO)

Tern Plc (LON:TERN), the company focused on value creation from Internet of Things (“IoT”) technology businesses, has announced that a recording of the investor webinar held on Tuesday 21 November 2023 and featuring presentations by Tern’s portfolio companies Device Authority, Wyld Networks and Talking Medicines, together with a question and answer session, is available to view below:

Video presentation of Tern PLC Capital Markets Day held on 21 November 2023. Presenters include Ian Ritchie and Al Sisto from Tern PLC together with Darron Antill from Device Authority, Jo Halliday from Talking Medicines and Alastair Williamson from Wyld Networks.

Tern Plc is using its experience in pioneering leading-edge tech combined with a deep reach into expanding world markets to unlock the potential of UK companies who may be starting local, but are dreaming global. If you are a company seeking to disrupt existing markets, or even creating a whole new sector, tern is the long term partner who can help you change your business, and then the world, for the better.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Tern Plc reports 2025 results and outlines portfolio value strategy

Tern plc has reported audited annual results, outlined portfolio developments and convened a General Meeting for 9 July 2026.

Device Authority targets enterprise IoT security demand through Xalient partnership

Device Authority has partnered with Xalient to bring KeyScaler into managed enterprise security services, strengthening its position in scalable IoT and OT device identity management.

Talking Medicines targets a clearer view of GLP-1 and cancer care demand

Talking Medicines is showing why real-world healthcare conversations matter for investors tracking GLP-1, oncology and the next stage of life sciences market positioning.

GLP-1 cancer signals add a new investor angle

Early oncology signals from ASCO 2026 add a new investor angle to the GLP-1 story, with further research needed before clinical or commercial conclusions can be drawn.

Device Authority expands enterprise reach through IoT security partnership

Device Authority’s partnership with Xalient strengthens its enterprise IoT security positioning as regulated industries look for scalable, automated ways to manage connected device risk.

Pharma engagement shifts from reach to relevance

Pharma engagement is moving from broad reach to relevant messaging across connected patient journeys.

Search